Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 94 results found. Search for [ COVID-19 antibody drug ]

Results 20 to 40 of 94
Chitranjan Kumar
October 28, 2020
Validated and approved by ICMR and the National Institute of Virology (NIV), Pune, Cipla's ELIfast is found to have specificity and sensitivity of 99.33 per cent and 92 per cent, respectively


PTI
October 27, 2020
Speaking to reporters after a meeting with AstraZeneca Managing Director Gagan Singh Bedi, he said the first phase of trials of the vaccine were encouraging


Reuters
October 27, 2020
President Donald Trump received a similar experimental antibody drug from Regeneron Pharmaceuticals Inc on an emergency basis when he was sickened with the coronavirus earlier this month


PB Jayakumar
October 22, 2020
Serum Institute of India (SII) has teamed up with Merck KGaA, Germany, to develop COVID-19 fighting monoclonal antibodies (mAbs), made by cloning a unique white blood cell to increase immunity and fight diseases, along with drug research driven nonprofit scientific research organization IAVI and Scripps Research


Reuters
October 16, 2020
The American company said the data appeared inconsistent, the findings were premature and that other studies had validated the drug's benefits


PTI
October 14, 2020
Trump, who tested positive for COVID-19 on October 1 and was admitted to a military hospital for three nights and four days, declared himself cured after he was treated with an experimental antibody drug cocktail


BusinessToday.In
October 14, 2020
Dr Reddy's has teamed up with Russian Development Investment Fund (RDIF) to conduct trials and distribute 100 million doses of Sputnik V in India


Reuters
October 14, 2020
Trump touted the Lilly drug, along with the antibody treatment from Regeneron Pharmaceuticals Inc that he received for his COVID-19, as tantamount to a cure in a video he posted last week


BusinessToday.In
October 14, 2020
India Stock Market Highlights Today: Tata Steel, Bharti Airtel, HCL Tech, Asian Paints and Bajaj Auto were among the top laggards today. On the other hand, ONGC, followed by NTPC, PowerGrid, UltraTech Cement, ITC, HDFC Bank, ICICI Bank and HDFC were among the top gainers.


BusinessToday.In
October 13, 2020
Scientists from the University of Toronto and the Lunenfeld-Tanenbaum Research Institute at Sinai Health used both blood samples and saliva from coronavirus patients to assess and compare antibody levels for over three months post the onset of the first symptom


Reuters
October 10, 2020
The agreement, under the Trump administration's Operation Warp Speed, is for developing a monoclonal antibody cocktail that can prevent COVID-19


BusinessToday.In
October 8, 2020
Donald Trump, who was admitted at Walter Reed National Military Medical centre on Friday, had received \"a single 8-gram dose\" of Regeneron's monoclonal antibody cocktail


BusinessToday.In
September 24, 2020
India Stock Market Highlights Today: All Sensex components were in the red with M&M, Bajaj Finance, IndusInd Bank, Maruti, Axis Bank, Bajaj Finserv and ICICI Bank shedding up to 33%.


Reuters
August 25, 2020
Soumya Swaminathan, WHO chief scientist, said only a few clinical trials of convalescent plasma have produced results, and the evidence, at least so far, has not been convincing enough to endorse it beyond use as an experimental therapy


Reuters
August 24, 2020
The S&P 500 and the Nasdaq scaled new heights on Monday, boosted by technology mega-caps and U.S. approval for the emergency use of blood plasma in treating COVID-19 patients


PTI
August 17, 2020
Sputnik V has been developed by the Gamaleya Research Institute of Epidemiology and Microbiology along with the Russian Direct Investment Fund (RDIF)


Dr. Swati Piramal
August 10, 2020
Partnerships and collaborations, especially those through a Public-Private-Partnership (PPP) model with governments, will indeed play a key role in advancing public health and the economy in this COVID era


Associated Press
August 4, 2020
The Trump administration responds that nursing homes could cover the cost of ongoing testing from a 5 billion pot provided by Congress, and allocated to the facilities by the White House


Reuters
August 4, 2020
The Phase III trial is expected to enroll up to 2,400 participants who live or work at facilities that have had a recently diagnosed case of COVID-19


PB Jayakumar
July 29, 2020
Last week, the DCGI had cancelled the rapid diagnostic kit import licences of three firms and suspended that of 16 others saying the US drug regulator USFDA has removed the manufacturers from their list of coronavirus serology test kits, with directions that they should not be distributed


PAGES 2 OF 5  12345